---
layout: post
title: "南新制药股东拟减持不超6%公司股份"
date: 2022-03-04 20:25:58 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<center><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688189" data-code="688189|1|1" data-code2="688189|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688189&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688189_0" data-code="K 688189|1|1" data-code2="K 688189|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p></center><p>南新制药公告，持股7.71%的股东鼎晖投资计划通过集中竞价交易方式或大宗交易方式合计减持公司股份不超过8,400,000股，不超过公司股份总数的6%。</p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203042297556142>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)